Hester Bios (HESTERBIO)
FAST GROWERFairStock Score: 32/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,479.25 |
| Market Cap | ₹1,328.86 Cr |
| P/E Ratio | 32.45 |
| ROCE | 9.71% |
| ROE | 10.87% |
| Dividend Yield | 0.45% |
| Profit Growth | -24.79% |
| Debt/Equity | 0.61 |
| Sales Growth | 22.46% |
| Promoter Holding | 53.73% |
| 52-Week Range | ₹1,239.3 — ₹2,350 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹388.99 |
Hester Bios trades with a P/E ratio of 32.45, ROCE of 9.71%, ROE of 10.87%, profit growth of -24.79%, debt-to-equity of 0.61. The FairStock Score of 32/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer